Noelle Gillette Cloven, M.D.

Provider Type: Physician

Specialties:

Gynecologic Oncology

Board Certifications:

Gynecologic Oncology
Obstetrics and Gynecology

Texas Oncology-Fort Worth Cancer Center
500 South Henderson St.
Fort Worth, TX 76104
T: 817-413-1500
contact_phone Download Contact Card

Metro Area: Fort Worth

Spoken Languages: English, Spanish

Downloads

Biography

General Summary

Dr. Cloven is a highly trained specialist with additional medical education in surgery, chemotherapy and radiation for the treatment of cervical, endometrial or uterine, ovarian, vulvar, and vaginal cancers. She is also trained in risk reducing surgery for women at increased risk for gynecologic cancers and fertility sparing surgery.

Education

Fellowship in Gynecologic Oncology
University of California, Irvine, CA
Residency in Gynecologic Oncology
University of California, Irvine, CA
Medical Doctorate
Baylor College of Medicine, Houston, TX

Accolades & Memberships

Associate Professor, TCU and UNTHSC School of Medicine, Fort Worth, TX (2020 to present)
Adjunct Clinical Assistant Professor, Department of PA Studies, School of Health Sciences, University of North Texas Health Science Center, Fort Worth, TX (2010 to present)
Alpha Omega Alpha Honor Medical Society
American College of Obstetricians and Gynecologists Fellow
Associate Chair of the Gynecologic Research Program, US Oncology (2012 to present)
Fort Worth Surgical Society (2014 to present)
Fellow, American College of Obstetricians and Gynecologists
Full Member Society of Gynecologic Oncologists (2004 to present)
Member Metropolitan Omaha Medical Society (2001 – 2009)
National Charity League, Fort Worth Chapter (2012 to present)
Outstanding Preceptor, UNT Health Science Center, PA Studies (2011 – 2020)
Society of Gynecologic Oncologists
Tarrant County Medical Society (2012 to present)
Top Doctors, Fort Worth Texas Magazine (2011 – 2021)
Top Doctors, 360 West Magazine (2019 – 2020)
Top Doctor, Texas Monthly Magazine (2020 – 2021)

Surgery Locations

Baylor Scott & White All Saints Medical Center – Fort Worth
Baylor Scott & White Surgicare Fort Worth
Texas Health Harris Methodist Hospital Fort Worth

Conditions

Procedures

Laparoscopic/ Davinci Robot
- Davinci/robotic total hysterectomy bilateral salpingo-oophorectomy
- Davinci/robotic bilateral salpingo-oophorectomy or cystectomy
- Davinci/robotic resection of pelvic mass
- Ovarian cancer primary or interval debulking/resection, staging
- Sentinel node mapping, pelvic, retroperitoneal, para aortic lymphadenectomy
Laparotomy/ Open Approach
- Total abdominal hysterectomy bilateral salpingo-oophorectomy
- Radical hysterectomy bilateral salpingo-oophorectomy, lymphadenectomy
- Exploratory laparotomy
- Laparotomy resection and or open excision of pelvic mass/malignancy, omentectomy, staging
- Excision of vaginal mass
- D&C with or without hysteroscopy
- Colposcopy
- Cold knife cone
- Smit sleeve placement for brachytherapy
- Laser of cervix, vulva and vagina
- Full or partial vaginectomy
- Simple partial or complete vulvectomy
- Radical partial or complete vulvectomy with inguinal lymphadenectomy and sentinel node mapping
- Wide local excision of vulvar mass

Publications

Velaparib With First-Line Chemotherapy and As Maintenance Therapy in Ovarian Cancer
The New England Journal of Medicine, 2019
Quality of Life in Patients With Newly Diagnosed Advanced Ovarian Cancer Treated With Niraparib Versus Placebo: Phase 3, Randomized, Controlled PRIMA/ENGOT-OV26/GOG-3012 Trial
Lancet Oncology, 2019
Veliparib With First-Line Chemotherapy and As Maintenance Therapy in Ovarian Cancer
The New England Journal of Medicine, 2019
Niraparib Monotherapy for Late-Line Treatment of Ovarian Cancer (QUADRA): A Multicentre, Open-Label, Single-Arm, Phase 2 Trial
The Lancet. Oncology, 2019
We Need a New Paradigm in Gynecologic Cancer Care: SGO Proposes Solutions for Delivery, Quality and Reimbursement Policies
Gynecologic Oncology, 2013

Show all Publications

Suppression of Ovarian Cancer Cell Tumorigenicity and Evasion of Cisplatin Resistance Using a Truncated Epidermal Growth Factor Receptor in a Rat Model
Cancer Research, 2005
The Impact of Complete Surgical Staging on Adjuvant Treatment Decisions in Endometrial Cancer
Gynecologic Oncology, 2004
In Vitro Chemoresistance and Biomarker Profiles are Unique for Histologic Subtypes of Epithelial Ovarian Cancer
Gynecologic Oncology, 2004
Bowel Resection During Primary Surgical Debulking for Epithelial Ovarian Cancer
Journal of the American College of Surgeons, 2001
Evaluation of D-Methionine as a Cytoprotectant in Cisplatin. Treatment of an Animal Model for Ovarian Cancer
Anticancer Research, 2000
Management of Ovarian-Cancer in Patients Older than Eighty
Gynecologic Oncology, 1999
Extraovarian Primary Peritoneal Carcinoma
Oncology, 1998
Aortic Valve Replacement in the Elderly
Circulation, 1993

Latest News

Show all News

Community Service

Associate Chair, Gynecologic Research Program, US Oncology (2012 to present)
GOG Partners Investigators Council (2020)
GOG Foundation, co-chair Communications Committee (2018)
NRG Oncology, member Communications Committee (2019)
Tarrant County Cancer Disparities Task Force (2012)

Research Interest

Dr. Cloven is actively involved in the most current clinical trials through US Oncology research network and the GOG Foundation. Fort Worth Cancer Center has many active trails for endometrial, ovarian, and cervical cancers.

Other Information

Dr. Cloven is married with three children and two goldendoodles.